微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 9.87% | -9.12% | 60.49% | 4/141 | 2.01% | 惠泰医疗 | 15.7% | 行业排名> |
| 2026-03-31 | 6.15% | 11.82% | -59.86% | 2/141 | 1.2% | 惠泰医疗 | 7.54% | 行业排名> |
| 2025-12-31 | 15.32% | -38.99% | 11.5% | 6/141 | 2.37% | 惠泰医疗 | 27.72% | 行业排名> |
| 2025-09-30 | 13.74% | -41.38% | 26.52% | 5/141 | 4.19% | 惠泰医疗 | 22.41% | 行业排名> |
| 2025-06-30 | 10.86% | -32.5% | 97.45% | 3/141 | 2.43% | 惠泰医疗 | 15.03% | 行业排名> |
| 2025-03-31 | 5.5% | -38.68% | -78.1% | 3/141 | 1.42% | 迈瑞医疗 | 7.06% | 行业排名> |
| 2024-12-31 | 25.11% | 104.65% | 7.12% | 3/141 | 4.14% | 迈瑞医疗 | 31.95% | 行业排名> |
| 2024-09-30 | 23.44% | 109.85% | 45.68% | 3/141 | 5.03% | 迈瑞医疗 | 28.68% | 行业排名> |
| 2024-06-30 | 16.09% | 127.26% | 79.38% | 2/141 | 3.15% | 迈瑞医疗 | 20.2% | 行业排名> |
| 2024-03-31 | 8.97% | 67.66% | -26.89% | 2/141 | 1.75% | 迈瑞医疗 | 9.12% | 行业排名> |
| 2023-12-31 | 12.27% | -49.44% | 9.85% | 22/141 | 5.44% | 迈瑞医疗 | 33.21% | 行业排名> |
| 2023-09-30 | 11.17% | -55.5% | 57.77% | 19/141 | 6.06% | 迈瑞医疗 | 28.34% | 行业排名> |
| 2023-06-30 | 7.08% | -63.37% | 32.34% | 24/141 | 3.96% | 迈瑞医疗 | 18.36% | 行业排名> |
| 2023-03-31 | 5.35% | -43.68% | -77.96% | 14/141 | 2.33% | 万泰生物 | 9.6% | 行业排名> |
| 2022-12-31 | 24.27% | -32.88% | -3.31% | 18/141 | 13.33% | 九安医疗 | 146.56% | 行业排名> |
| 2022-09-30 | 25.1% | -10.83% | 29.85% | 17/141 | 13.94% | 九安医疗 | 140.94% | 行业排名> |
| 2022-06-30 | 19.33% | -10.63% | 103.47% | 15/141 | 9.74% | 九安医疗 | 142.25% | 行业排名> |
| 2022-03-31 | 9.5% | -1.14% | -73.73% | 17/141 | 6.8% | 九安医疗 | 142.71% | 行业排名> |
| 2021-12-31 | 36.16% | 5.3% | 28.45% | 13/141 | 18.45% | 热景生物 | 121.78% | 行业排名> |
| 2021-09-30 | 28.15% | 3.68% | 30.14% | 14/141 | 16.59% | 热景生物 | 99.69% | 行业排名> |
| 2021-06-30 | 21.63% | 19.77% | 125.08% | 12/141 | 11.59% | 热景生物 | 99.09% | 行业排名> |
| 2021-03-31 | 9.61% | 16.2% | -72.02% | 16/141 | 6.49% | 热景生物 | 57.63% | 行业排名> |
| 2020-12-31 | 34.34% | 24.2% | 26.48% | 24/141 | 26.27% | 中红医疗 | 168% | 行业排名> |
| 2020-09-30 | 27.15% | 18.3% | 50.33% | 16/141 | 19.98% | 圣湘生物 | 112.46% | 行业排名> |
| 2020-06-30 | 18.06% | 16.59% | 118.38% | 25/141 | 15.17% | 博拓生物 | 108.13% | 行业排名> |
| 2020-03-31 | 8.27% | 12.67% | -70.09% | 8/141 | 3.31% | 圣湘生物 | 29.33% | 行业排名> |
| 2019-12-31 | 27.65% | 20.01% | 20.48% | 19/141 | 14.66% | 健尔康 | 84.09% | 行业排名> |
| 2019-09-30 | 22.95% | 14.52% | 48.16% | 6/141 | 10.54% | 祥生医疗 | 28.56% | 行业排名> |
| 2019-06-30 | 15.49% | 28.98% | 111.04% | 5/141 | 6.76% | 心脉医疗 | 31.04% | 行业排名> |
| 2019-03-31 | 7.34% | 17.25% | -68.14% | 3/141 | 2.73% | 新华医疗 | 13.55% | 行业排名> |
| 2018-12-31 | 23.04% | 20.31% | 14.97% | 24/141 | 14.23% | 安旭生物 | 48.71% | 行业排名> |
| 2018-09-30 | 20.04% | 23.25% | 66.86% | 4/141 | 9.71% | 迈瑞医疗 | 38.33% | 行业排名> |
| 2018-06-30 | 12.01% | 14.49% | 91.85% | 3/141 | 4.54% | *ST明德 | 14.54% | 行业排名> |
| 2018-03-31 | 6.26% | 27.49% | -67.31% | 2/141 | 2.78% | 迈瑞医疗 | 11% | 行业排名> |
| 2017-12-31 | 19.15% | -17.21% | 17.77% | 30/141 | 14.51% | 安旭生物 | 59.22% | 行业排名> |
| 2017-09-30 | 16.26% | -15.18% | 55% | 7/141 | 9.49% | 大博医疗 | 30.55% | 行业排名> |
| 2017-06-30 | 10.49% | -33.52% | 113.65% | 11/141 | 6.11% | 基蛋生物 | 23.11% | 行业排名> |
| 2017-03-31 | 4.91% | -36.65% | -78.77% | 3/141 | 2.74% | 基蛋生物 | 11.34% | 行业排名> |
| 2016-12-31 | 23.13% | -39.59% | 20.66% | 18/141 | 16.44% | 奥泰生物 | 76.87% | 行业排名> |
| 2016-09-30 | 19.17% | 2% | 21.48% | 4/141 | 8.86% | 安图生物 | 28% | 行业排名> |
| 2016-06-30 | 15.78% | -6.13% | 103.61% | 4/141 | 6.35% | *ST明德 | 23.29% | 行业排名> |
| 2016-03-31 | 7.75% | 2% | -79.76% | 1/141 | 2.3% | 健帆生物 | 7.75% | 行业排名> |